SWM
APYX icon

SeaCrest Wealth Management’s Apyx Medical APYX Stock Holding History

SeaCrest Wealth Management’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,000
Closed -$4K – 2251
2018
Q2 		$4K Hold
1,000
– – ﹤0.01% 1852
2018
Q1 		$3K Hold
1,000
– – ﹤0.01% 1884
2017
Q4 		$3K Buy
+1,000
New +$3.12K ﹤0.01% 1909

Other funds holding APYX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
HK
Horizon Kinetics New York $3.06B AUM 5.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SeaCrest Wealth Management's APYX Position: Q3 2018 in Review

SeaCrest Wealth Management sold out of Apyx Medical (APYX) in Q3 2018, closing a stake of 1,000 shares — an estimated $4K sold.

SeaCrest Wealth Management first reported a position in APYX in Q4 2017 and held it in 3 quarters. The position peaked at $4K in Q2 2018. 56 funds tracked by Wall St. Rank hold APYX as of Q3 2018.

  • SeaCrest Wealth Management reported no remaining Apyx Medical position as of Q3 2018 after selling out during the quarter.
  • SeaCrest Wealth Management sold 1,000 Apyx Medical shares in Q3 2018, an estimated $4K.
  • SeaCrest Wealth Management first reported a position in Apyx Medical in Q4 2017 and held it in 3 quarters.
  • SeaCrest Wealth Management's Apyx Medical position peaked at $4K in Q2 2018.
  • 56 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2018.

Based on SeaCrest Wealth Management's 13F filing for Q3 2018, filed 14 Nov 2018.